Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Adjuvant Therapeutics

Out of Business LATEST DEAL TYPE

Developer of a cancer treatment technology designed to improve cancer treatment. The company's technology offers a system called OncO2, that increase oxygen concentrations in tumors, enabling physicians to improve the effectiveness of radiotherapy for cancer treatment.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Primary Office
  • 1344 Summer Street
  • Suite 311.1
  • Halifax, Nova Scotia B3H 0A8
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adjuvant Therapeutics’s full profile, request a free trial.

Adjuvant Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Adjuvant Therapeutics Executive Team (1)

Name Title Board
Cliff Ansel Chief Executive Officer